Content related to Staff Spotlight: Jean-Hugues Parmentier, PhD

Children’s Hospital Los Angeles researchers develop a pediatric solid tumor liquid biopsy for use when obtaining a tissue biopsy is not feasible.

CHLA team discover genetic variants in both nuclear DNA and mitochondrial DNA genomes implicated in tumorigenesis of pediatric chordoma.

Jesse Berry, MD, shares how CHLA’s pioneering liquid biopsy is personalizing care for retinoblastoma.

Dr. Sedrakyan is studying interventions to address the mechanisms behind Alport syndrome, a genetic condition that can lead to kidney disease.

As a Bioinformatics Specialist in CHLA’s Spatial Biology and Genomics Core, Dr. Ding helps to extract the meaning out of “noisy” biological data.

A more aggressive treatment regimen for clear cell sarcoma has transformed survival rates for children with the disease.

Not everyone sees their dream job come true, but 22-year-old Bryant Valdovinos did. Thanks to his successful completion of a Project SEARCH internship at Children’s Hospital Los Angeles, Valdovinos is

Fredda De La Torre joined CHLA in early 2022 to work on the HEALthy Brain and Child Development Study—a groundbreaking national study that aims to better understand how environmental factors influence